Literature DB >> 31562618

Immunoresolvent Resolvin D1 Maintains the Health of the Ocular Surface.

Darlene A Dartt1,2, Robin R Hodges3,4, Charles N Serhan5,6.   

Abstract

The present review focuses on the role of one of the D-series resolvins (Rv) RvD1 in the regulation of conjunctival goblet cell secretion and its role in ocular surface health. RvD1 is the most thoroughly studied of the specialized proresolution mediators in the goblet cells. The anterior surface of the eye consists of the cornea (the transparent central area) and the conjunctiva (opaque tissue that surrounds the cornea and lines the eyelids). The secretory mucin MUC5AC produced by the conjunctival goblet cells is protective of the ocular surface and especially helps to maintain clear vision through the cornea. In health, a complex neural reflex stimulates goblet cell secretion to maintain an optimum amount of mucin in the tear film. The specialized pro-resolution mediator, D-series resolvin (RvD1) is present in human tears and induces goblet cell mucin secretion. RvD1 interacts with its receptors ALX/FPR2 and GPR32, activates phospholipases C, D, and A2, as well as the EGFR. This stimulation increases the intracellular [Ca2+] and activates extracellular regulated kinase (ERK) 1/2 to cause mucin secretion into the tear film. This mucin secretion protects the ocular surface from the challenges in the external milieu thus maintaining a healthy interface between the eye and the environment. RvD1 forms a second important mechanism along with activation of a neural reflex pathway to regulate goblet cell mucin secretion and protect the ocular surface in health.

Entities:  

Keywords:  Allergic eye disease; Conjunctiva; Dry eye disease; Goblet cells; Inflammation; Mucins; Ocular surface; Resolvin D1; Secretion; Signaling pathways; Tear film

Mesh:

Substances:

Year:  2019        PMID: 31562618      PMCID: PMC6859005          DOI: 10.1007/978-3-030-21735-8_3

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  51 in total

Review 1.  VPAC and PAC receptors: From ligands to function.

Authors:  Louise Dickson; Keith Finlayson
Journal:  Pharmacol Ther       Date:  2008-12-06       Impact factor: 12.310

Review 2.  Conjunctival epithelial and goblet cell function in chronic inflammation and ocular allergic inflammation.

Authors:  Darlene A Dartt; Sharmila Masli
Journal:  Curr Opin Allergy Clin Immunol       Date:  2014-10

3.  Relation between Ocular Comfort, Arachidonic Acid Mediators, and Histamine.

Authors:  Simin Masoudi; Zhenjun Zhao; Mark Willcox
Journal:  Curr Eye Res       Date:  2017-01-31       Impact factor: 2.424

4.  Immunolocalization of muscarinic and VIP receptor subtypes and their role in stimulating goblet cell secretion.

Authors:  J D Ríos; D Zoukhri; I M Rawe; R R Hodges; J D Zieske; D A Dartt
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-05       Impact factor: 4.799

Review 5.  Functions of ocular surface mucins in health and disease.

Authors:  Flavio Mantelli; Pablo Argüeso
Journal:  Curr Opin Allergy Clin Immunol       Date:  2008-10

6.  Localization of nerves adjacent to goblet cells in rat conjunctiva.

Authors:  D A Dartt; D M McCarthy; H J Mercer; T L Kessler; E H Chung; J D Zieske
Journal:  Curr Eye Res       Date:  1995-11       Impact factor: 2.424

Review 7.  Pro-resolving lipid mediators are leads for resolution physiology.

Authors:  Charles N Serhan
Journal:  Nature       Date:  2014-06-05       Impact factor: 49.962

8.  High levels of anti-inflammatory and pro-resolving lipid mediators lipoxins and resolvins and declining docosahexaenoic acid levels in human milk during the first month of lactation.

Authors:  Gisela Adrienne Weiss; Heinz Troxler; Glynis Klinke; Daniela Rogler; Christian Braegger; Martin Hersberger
Journal:  Lipids Health Dis       Date:  2013-06-15       Impact factor: 3.876

9.  Resolvin D1 and aspirin-triggered resolvin D1 regulate histamine-stimulated conjunctival goblet cell secretion.

Authors:  D Li; R R Hodges; J Jiao; R B Carozza; M A Shatos; N Chiang; C N Serhan; D A Dartt
Journal:  Mucosal Immunol       Date:  2013-03-06       Impact factor: 7.313

10.  ω-3 Tear Film Lipids Correlate With Clinical Measures of Dry Eye.

Authors:  Scott D Walter; Karsten Gronert; Allison L McClellan; Roy C Levitt; Konstantinos D Sarantopoulos; Anat Galor
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-05-01       Impact factor: 4.799

View more
  7 in total

1.  Preclinical Efficacy Comparison of Cyclosporine Ophthalmic Solution 0.09% vs Cyclosporine Ophthalmic Emulsion 0.05% vs Ciclosporin Ophthalmic Emulsion 0.1% in a NOD Mouse Model of Dry Eye Disease.

Authors:  Vinod Burade; Rishit Zalawadia; Alpesh Patel; Abayomi Ogundele
Journal:  Clin Ophthalmol       Date:  2020-09-21

2.  Signaling Pathways Used by the Specialized Pro-Resolving Mediator Maresin 2 Regulate Goblet Cell Function: Comparison with Maresin 1.

Authors:  Markus V Olsen; Anne V Lyngstadaas; Jeffrey A Bair; Robin R Hodges; Tor P Utheim; Charles N Serhan; Darlene A Dartt
Journal:  Int J Mol Sci       Date:  2022-06-02       Impact factor: 6.208

Review 3.  The potential of lipid mediator networks as ocular surface therapeutics and biomarkers.

Authors:  Becca A Flitter; Xiaohui Fang; Michael A Matthay; Karsten Gronert
Journal:  Ocul Surf       Date:  2020-04-29       Impact factor: 5.033

4.  Dynamics of DHA and EPA supplementation: incorporation into equine plasma, synovial fluid, and surfactant glycerophosphocholines.

Authors:  Undine Christmann; Courtney L Hancock; Cathleen M Poole; Audrey L Emery; Jesse R Poovey; Casey Hagg; Eric A Mattson; Jon J Scarborough; Jordan S Christopher; Alexander T Dixon; Dustin J Craney; Paul L Wood
Journal:  Metabolomics       Date:  2021-04-17       Impact factor: 4.290

Review 5.  Possible protective effect of resolvin D1 on inflammation in atrial fibrillation: involvement of ER stress mediated the NLRP3 inflammasome pathway.

Authors:  Fatemeh Yarmohammadi; A Wallace Hayes; Gholamreza Karimi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-07-03       Impact factor: 3.000

6.  Resolvin D1 and D2 inhibit tumour growth and inflammation via modulating macrophage polarization.

Authors:  Kai Shan; Ninghan Feng; Jing Cui; Shunhe Wang; Hongyan Qu; Guoling Fu; Jiaqi Li; Heyan Chen; Xiaoying Wang; Rong Wang; Yumin Qi; Zhennan Gu; Yong Q Chen
Journal:  J Cell Mol Med       Date:  2020-05-29       Impact factor: 5.310

Review 7.  A review of non-prostanoid, eicosanoid receptors: expression, characterization, regulation, and mechanism of action.

Authors:  Roger G Biringer
Journal:  J Cell Commun Signal       Date:  2021-06-26       Impact factor: 5.782

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.